Farming is undergoing a quiet transformation as growers around the world look for ways to protect crops and boost yields without leaning so heavily on synthetic chemicals. This shift is reflected in the expanding agricultural biologicals market, where nature-derived inputs such as beneficial microbes, plant extracts, and biological pest controls are increasingly replacing conventional agrochemicals. As health-conscious consumers demand more organic produce and governments push sustainability agendas, biological crop solutions are moving from a niche category into the mainstream of modern agriculture.
Market Size and Growth Trajectory
The global market for agricultural biologicals has been on a steep upward curve. Valued at roughly USD 15.25 billion in 2023, it climbed to an estimated USD 17.25 billion in 2024 and is forecast to reach approximately USD 46.11 billion by 2031. That trajectory implies a compound annual growth rate of around 15%, a pace that far outstrips most segments of the broader agricultural inputs industry. This rapid expansion isn’t happening in isolation — it mirrors a global pivot toward regenerative and organic farming practices, along with tightening regulations on synthetic pesticide residues in food.
Several major players are shaping this space, including Novonesis Group, Bayer Crop Science, BASF, Corteva, Valent BioSciences, Koppert, UPL, FMC Corporation, Andermatt Group, and Certis USA. These companies are pouring resources into research, product diversification, and geographic expansion to capture a larger share of an increasingly crowded but lucrative market.
What’s Driving the Boom?
At the heart of this growth is a simple but powerful consumer trend: people want food grown without synthetic chemical residues. That preference cascades down the supply chain, encouraging farmers to adopt biocontrols, biofertilizers, and biostimulants as substitutes for or complements to traditional agrochemicals. These biological products don’t just check a marketing box — they genuinely help improve soil health, strengthen plant resilience, and reduce the ecological footprint of farming operations.
Regulatory frameworks are also playing a supportive role. In the United States, the Coordinated Framework for Biotechnology establishes federal oversight designed to build public trust in biotech-derived agricultural products, which in turn smooths the path for wider adoption. India offers another compelling example: government programs like the Paramparagat Krishi Vikas Yojana and the Mission Organic Value Chain Development scheme have been actively training farmers and subsidizing the transition to organic inputs since the mid-2010s, giving the biologicals sector a meaningful policy tailwind.
That said, the market isn’t without friction. A persistent obstacle is the knowledge gap among farmers, many of whom simply aren’t familiar with how to properly use biological products or what benefits they offer relative to conventional chemicals. Closing this gap will require sustained investment in extension services, field demonstrations, and accessible training resources — an area where industry-government collaboration could pay significant dividends.
Industry Trends Worth Watching
Research and development spending is accelerating across the sector, with companies racing to create more precise, region-specific formulations. Rather than one-size-fits-all products, manufacturers are increasingly tailoring biologicals to particular crops, climates, and soil conditions — a trend that should improve efficacy and, in turn, farmer confidence in these products.
Soil health has also emerged as a central theme. As awareness grows about the long-term costs of soil degradation from intensive chemical farming, biofertilizers and biostimulants that nurture soil microbiomes are seeing rising demand. This isn’t just an environmental win; healthier soil directly supports better yields and long-term farm productivity.
Partnerships between established agrochemical giants and biotech innovators are becoming a defining feature of the competitive landscape. A notable example came in late 2024, when AgroSpheres and BASF announced a collaboration to develop a novel bioinsecticide using AgroSpheres’ proprietary biomolecule technology. Early trial results have shown strong efficacy against lepidopteran pests even at low application rates — the kind of performance breakthrough that could accelerate mainstream adoption of biological pest control.
Breaking Down the Market by Segment
The agricultural biologicals market is typically analyzed across four dimensions: source, category, application, and crop type.
By source, the market splits into microbials, macrobials, natural products, and semiochemicals. Microbials — derived from bacteria, fungi, viruses, and algae — are expected to grow at nearly 15% annually, driven by their effectiveness as both pest control agents and soil enhancers.
By category, biocontrols led the pack in 2023 with roughly USD 7.64 billion in value. These products, which include bio-insecticides, bio-fungicides, and bio-herbicides, are gaining traction because they offer a natural alternative to synthetic pesticides without disrupting beneficial organisms in the ecosystem. A good illustration of this momentum came in April 2024, when Sumitomo Corporation invested in Chilean biocontrol manufacturer Bio Insumos Nativa through its South American agrochemical distribution arm.
By application, foliar spray dominates, capturing over half of total revenue in 2023. This method delivers nutrients and protective compounds directly onto plant leaves, allowing for faster absorption and more targeted intervention — particularly useful for addressing nutrient deficiencies or sudden pest outbreaks.
Regional Dynamics
North America currently leads the global market, accounting for roughly 36% of total revenue in 2023 with a valuation near USD 5.44 billion. The region benefits from mature regulatory pathways that streamline biopesticide and biofertilizer approvals, combined with strong consumer demand for organic food and substantial private and public R&D investment.
Asia Pacific, meanwhile, is set to be the fastest-growing region, with an anticipated CAGR above 16%. Countries like China, India, and Japan are grappling with pesticide resistance and soil degradation on a large scale, which is pushing farmers toward biological alternatives. Rising government support for organic agriculture, combined with growing awareness and increased capital flowing into the sector, positions Asia Pacific as a critical growth engine for the industry over the coming years.
Competitive Landscape
This remains a fragmented market where no single company dominates outright. Instead, players are jockeying for position through mergers, acquisitions, joint ventures, and product innovation. FMC Corporation’s October 2024 partnership with Brazil’s Ballagro Agro Tecnologia is a case in point — the deal gives FMC access to fungi-based biosolutions while expanding its distribution footprint in Brazil, a critical agricultural market. Similarly, IPL Biologicals’ August 2024 partnership with Spain’s AFEPASA aims to bring IPL’s microbial biopesticides, including a promising nematicide, to European and eventually global markets.
What Lies Ahead
The agricultural biologicals sector is positioned for continued rapid expansion as the twin pressures of consumer demand for cleaner food and regulatory tightening on synthetic chemicals converge. Companies that can successfully bridge the awareness gap among farmers, while continuing to innovate on efficacy and affordability, stand to capture outsized value in a market projected to nearly triple in size by 2031. For agribusinesses, input manufacturers, and investors alike, agricultural biologicals represent one of the more compelling long-term growth stories in the broader crop protection and soil health ecosystem.
